Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU’s COVID-19 IVD Guidelines Reflect Need For Nuanced Approach To Testing For Member States

Executive Summary

New European Commission guidelines on COVID-19 IVD tests and their performance not only explain the regulatory requirements, but also detail why different levels of precision may be acceptable in different contexts.

You may also be interested in...



New EU Guidelines Aim To Raise Regulatory Bar For COVID-19 Antibody Tests

Rapid COVID-19 antibody tests have been the subject of considerable criticism over the last year. With the prevalence of these tests skyrocketing and tighter IVD regulations still over a year away, the EU has come up with new guidance.

Germany’s COVID-19 Testing Leaps Again But Antibody Tests Not Ready

Acting early but not too soon has made Germany a model of COVID-19 preparedness. Its testing rates are still increasing, and a new app is designed to ensure even greater detection efficiency is being developed. An antibody test eludes, however.

Belgium Allows Reprocessing Of Single Use Devices And Relaxes In-House Manufacture Rules

The shortage of medical equipment to manage the COVID-19 pandemic is leading many countries to take measures to allow unregulated devices onto the market. Belgium is creating its own solutions.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126603

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel